Skip to content
Open Data Finder
Open Government Canada

Benzodiazepines: A look at the evolving illicit drug landscape

Published by Health Canada | Santé Canada

About this dataset

This one pager aim to offer an overview of the benzodiazepine landscape in Canada based on samples submitted to DAS laboratories between 2017 to 2026. The main take of the document is that the presence of benzodiazepines in Canada’s illicit drug supply has shifted over the past decade. Samples containing benzodiazepines increased sharply in 2020 (+40.1%) and peaked in 2021 (+119.6%). Following this peak, detections have declined year over year, decreasing by 16.6% in 2024 and 28.3% in 2025.

Benzodiazepines: A look at the evolving illicit drug landscape · Open Data Finder